At week 13 of the sell signal, Procter & Gamble shows a technical picture that is turning: CMF back positive, MACD recovering, and a double bottom in the 139 area that has halted the decline. The downtrend holds directionally, but has lost momentum.

Pfizer is in week 5 of a sell signal that has not confirmed: short-term indicators show growing buy-side pressure and a double bottom in the 25 area. The picture remains fragile, with trading not recommended.

PepsiCo is at week 12 of a sell signal. The week closed higher with dominant buying volume, while a double bottom has formed in the 141 area on the daily chart — a potential exhaustion signal worth watching.

PG&E is in week 11 of a sell signal. The AT picture shows mixed signals: buy volumes recovering and a daily double bottom in the 16 area, while CMF remains negative and the decline holds on a directional basis.

PBR is in its 2nd week of a sell signal on the New York Stock Exchange. The week was indecisive, but the trend remains bearish and the quality band flags trading as not recommended: the stock still trades 30% above the 200-week moving average.

Week 13 of the buy signal on Palo Alto Networks, model coverage complete. The trade is up 67%: the remaining 40% continues with the stop trailing the Inversion Point in the 247 area, locking in the accumulated gain.